P Auger

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text

Medicine, Molecular Biology, Oncology +15

Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies

Daniel Robbins, Mark Noviski, Ying Siow Tan et al. · Journal of Medicinal Chemistry · 2024 · 96 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete's foot

P Auger, G Marquis, Jeannine Joly et al. · Mycoses · 1993 · 84 citations

Medicine, Dermatology, Sports Medicine +15

Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence

Errol Reiss, Louis de Repentigny, R J Kuykendall et al. · Journal of Clinical Microbiology · 1986 · 48 citations · Full text

Life Sciences, Immunology, Microbiology +17

Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice

G Marquis, S Montplaisir, M Pelletier et al. · Infection and Immunity · 1985 · 43 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +13